Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease

Clinical trial NCT00329550 · COMPLETED

Trial details

NCT number: NCT00329550
Sponsor: UCB Japan Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2006-05-01
Primary completion: 2008-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.